Connect with us

Business

FDA authorizes emergency use of Regeneron antibody treatment given to Trump – Axios

Regeneron expects to have treatment doses ready for some 80,000 patients by November’s end.

Published

on

post featured image

The Food and Drug Administration announced Saturday evening it has granted emergency use authorization for Regeneron Pharmaceuticals’ antibody cocktail given to President Trump to treat his COVID-19 infection last month.
Why it matters: Regeneron’s two monoclonal antibodies, casirivimab and imdevimab, are for people who tested positive for the coronavirus and “who are at high risk for progressing to severe COVID-19,” including people who are 65 and older, and/or people with certain chronic illnesses,…

Click here to view the original article.